Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs.
about
Genome-editing Technologies for Gene and Cell TherapyPCSK9 inhibition: the way forward in the treatment of dyslipidemiaPCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic eraA century of cholesterol and coronaries: from plaques to genes to statinsPCSK9 Inhibition With Monoclonal Antibodies: Modern Management of HypercholesterolemiaPCSK9 and Atherosclerosis - Lipids and Beyond.Microsomal transfer protein inhibitors, new approach for treatment of familial hypercholesterolemia, review of the literature, original findings, and clinical significance.PCSK9 inhibition: current concepts and lessons from human genetics.Genetics of familial hypercholesterolemia.Targeting PCSK9 for therapeutic gainsStatin intolerance: diagnosis and remedies.LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015).The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9.The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol.Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice.Vaccine against PCSK9: the natural strategy from passive to active immunization for the prevention of atherosclerosis.PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies.New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia.Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.Familial hypercholesterolemia.Large-Scale Phenome-Wide Association Study of Variants Demonstrates Protection Against Ischemic Stroke
P2860
Q26769662-9CA25546-1518-431A-9903-D311A8C735C8Q26784482-50FB5A4B-6F98-4EB4-89EB-01D190ECBE3BQ28073656-A163ED56-FD5D-458D-9181-06A7DA9529BDQ28080618-BAC30C81-5D58-40CD-805E-F893595303CAQ28275648-B3380C72-85DE-4F97-8315-68EB50B2B89EQ33675963-A5CBFB32-569D-4B97-98C3-49702EA9B370Q38325807-8C6CA761-5164-4E3E-A85B-4BF85BF8279DQ38338236-22DFD365-FA59-4FC6-840D-EE045A35D616Q38364881-81E4E341-D2B0-49D9-B781-D188EB15CB12Q38364882-7BEE1FC5-9ED1-46A1-A08C-34D4456ED1E1Q38430744-F4B4A3F5-7ED6-4288-99FD-1E38A0044481Q38511045-6C4BD652-305C-4C0A-ACD8-BDD450C2B89EQ38796312-0CC9F5F9-EADF-4978-BED9-249F241DB11CQ38846832-62A4F577-22AB-4D8C-AA15-0E290EB31A84Q39030028-9A56A96C-61B2-4615-9FF8-DAD2A9F53022Q42367561-032B5539-F561-4D6D-8272-AD28DC9ADCCBQ47135490-B807A732-AA70-4E6D-99EF-E80464B775C2Q47141132-10EC56C7-C10B-48C8-A7A8-A924892C7174Q47567094-4C5C6F85-1A80-4A41-AD93-97B3BE912340Q48130479-7FD1AC8A-FD84-4A90-BE11-8300C6287376Q48282746-AD4FA01F-5CDE-4870-9244-50A1B3C98635Q53112365-15D23FAA-C72A-45E6-86B7-FACB50EFB16AQ55284678-F2B37061-D5DA-4C57-8156-3477CBE417C6Q57177843-9F991020-6203-40A8-B230-E446FB47E464
P2860
Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@ast
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@en
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@nl
type
label
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@ast
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@en
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@nl
prefLabel
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@ast
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@en
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@nl
P2093
P2860
P50
P1476
Living the PCSK9 adventure: fr ...... lass of anticholesterol drugs.
@en
P2093
Marianne Abifadel
Marie-Line Moussalli
Mélody Chémaly
Petra El Khoury
P2860
P2888
P356
10.1007/S11883-014-0439-8
P577
2014-09-01T00:00:00Z
P6179
1033791217